MindMaze Therapeutics (RLF)

Last close As at 11/12/2025

CHF2.86

0.05 (1.78%)

Market capitalisation

CHF40m

MindMaze Therapeutics (previously Relief Therapeutics) is a Swiss med-tech company advancing and commercialising a proprietary driven platform focused on neurotherapeutic solutions to treat neurological diseases (such as stroke and TBI), integrating software-based treatments with innovative technology, data and AI to improve patient outcomes.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Paolo Galfetti

    Chief Business Officer

  • Jeremy Meinen

    Chief Financial Officer